A hemostatic dressing is a wound covering impregnated or coated with an agent that accelerates blood clotting beyond what plain gauze can achieve. When packed into a deep wound or pressed against a bleeding site, these dressings interact with blood components to form a stable clot in minutes, buying time during emergencies when bleeding could otherwise be fatal. Originally developed for battlefield trauma, hemostatic dressings have steadily moved into civilian ambulances, emergency departments, and even home first-aid kits, though their mechanisms, effectiveness, and correct use vary more than most people realize.
How Hemostatic Dressings Stop Bleeding
All hemostatic dressings share the same basic goal: get a clot to form faster and hold together longer than it would with pressure alone. But the agents embedded in these dressings take different biochemical routes to get there. The three most common active ingredients in modern products are kaolin, chitosan, and oxidized cellulose, and each works through a distinct mechanism.
Kaolin is a naturally occurring mineral clay. When blood contacts kaolin particles on a dressing, the mineral activates clotting factors in the blood’s own coagulation cascade, essentially jump-starting the chain reaction that leads to a fibrin clot. QuikClot Combat Gauze, the most widely issued military hemostatic dressing, uses kaolin as its active agent. Because kaolin relies on the body’s existing clotting machinery, it depends on having at least some functional clotting factors present in the blood.
Chitosan takes a fundamentally different approach. Derived from the shells of shrimp and other crustaceans, chitosan is a positively charged polysaccharide that attracts red blood cells and platelets directly, pulling them together into a plug at the wound surface. This mechanism does not depend on the body’s normal clotting pathway, which is a meaningful advantage when someone is severely injured and their clotting system is already failing.1PubMed. A review on recent advances in chitosan based composite for hemostatic dressings Chitosan also has antibacterial properties, which matters in contaminated wounds.
Oxidized regenerated cellulose is a plant-based material processed into a knitted fabric and then chemically oxidized. When placed against a bleeding surface, it acts as a physical scaffold that supports clot formation while also lowering the local pH, which helps to seal small blood vessels.2PubMed Central. Evolution of hemostatic agents in surgical practice This type is used more often in surgical settings than in field trauma care.
A fourth category worth mentioning involves fibrin-based dressings, which deliver concentrated clotting proteins directly to the wound. These essentially skip the early stages of coagulation and go straight to the final step, providing the raw material for a clot. Fibrin dressings have shown dramatic results in animal models of severe liver injury: in one study of coagulopathic swine, a fibrin patch reduced posttreatment blood loss to roughly 770 mL compared to nearly 5,000 mL with standard packing, and survival at two hours was close to 90% versus zero for the control group.3Journal of Trauma and Acute Care Surgery. A Novel Biologic Hemostatic Dressing (Fibrin Patch) Reduces Blood Loss and Resuscitation Volume and Improves Survival in Hypothermic, Coagulopathic Swine With Grade V Liver Injury
Why Pressure Still Matters
A hemostatic dressing is not a magic patch you slap on and walk away from. The dressing needs to be packed tightly into the wound and then held with firm, sustained pressure. This is the step where most failures happen. In a randomized trial testing whether untrained civilians could use hemostatic dressings effectively, the two most common reasons for failure were not holding pressure long enough and not applying enough pressure in the first place.4PubMed. Layperson Ability and Willingness to Use Hemostatic Dressings: A Randomized, Controlled Trial The dressing’s chemical agent needs close contact with the bleeding tissue, and pressure is what creates that contact.
How long you hold pressure depends on the situation. In a study of patients with large femoral artery access sites after vascular procedures, hemostasis was achieved in about nine minutes of manual compression in roughly 90% of cases when a hemostatic dressing was used. The small number who needed longer compression averaged about 34 minutes.5PubMed. Hemostatic Wound Dressing for Postinterventional Hemostasis in Large Femoral Artery Access Sites For trauma wounds in the field, military guidelines generally recommend at least three minutes of direct pressure, though many training protocols call for longer. The point is that the dressing enhances what pressure does; it does not replace it.
The Military Origins
Hemostatic dressings exist in their current form largely because of battlefield medicine. Uncontrolled hemorrhage is the leading cause of preventable death in combat casualties, and tourniquets cannot reach every wound. Injuries to the neck, groin, and armpit, often called “junctional” wounds because they sit at the junction between the trunk and the limbs, are especially difficult to compress with a tourniquet. This is where hemostatic dressings became essential.
The U.S. military’s Tactical Combat Casualty Care guidelines first added QuikClot Combat Gauze (a kaolin-based product) in 2008. Over the following years, chitosan-based alternatives proved themselves in animal studies and field use. A review of the evidence found that chitosan gauze dressings like Celox Gauze and ChitoGauze showed equal effectiveness to Combat Gauze across many measures, and both products were added to the TCCC guidelines as approved alternatives.6PubMed. Management of External Hemorrhage in Tactical Combat Casualty Care: Chitosan-Based Hemostatic Gauze Dressings–TCCC Guidelines-Change 13-05 Years of use by U.S. and NATO forces in Afghanistan and Iraq produced no reported complications or side effects from chitosan-based products, which helped build confidence in their safety profile.7Military Medicine. Review of New Topical Hemostatic Dressings for Combat Casualty Care
The appeal of chitosan dressings for military medics goes beyond simple effectiveness. Because chitosan works independently of the body’s clotting cascade, it remains effective even when a casualty has lost so much blood that their remaining clotting factors are depleted, a condition called trauma-induced coagulopathy. A comparative study found that new-generation chitosan dressings achieved 100% survival for up to three to four hours with minimal blood loss in animal models of severe coagulopathy, outperforming kaolin-based standards, which showed about 86% survival with higher blood loss.8Acta medica Lituanica. Comparative Study of Haemostatic Agents in Tactical Environments and Their Impact on Survival Time before Evacuation
Junctional Wounds and Specialized Devices
Some of the hardest bleeding to control comes from wounds in spots where tourniquets and flat bandages simply cannot work well. The groin and axilla (armpit) are common examples. Several products have been developed specifically for these deep, irregularly shaped wounds.
XSTAT is one of the more unusual designs: a syringe-like applicator filled with small compressed cellulose sponges coated with chitosan. You inject the sponges into the wound cavity, where they rapidly expand and fill the space, creating pressure from the inside out. In a porcine study comparing XSTAT to Combat Gauze over a 72-hour observation period, both maintained hemostasis throughout. XSTAT was significantly faster to administer, taking about 1.4 minutes compared to 3.4 minutes for Combat Gauze, though it absorbed more blood.9Journal of Trauma and Acute Care Surgery. Evaluation of hemostatic devices in a randomized porcine model of junctional hemorrhage and 72-hour prolonged field care In a mass-casualty scenario or under fire, shaving two minutes off application time per casualty can matter enormously.
Another approach uses self-propelling dressings that contain thrombin and tranexamic acid, designed to push clotting agents deep into a wound cavity. In a swine model of lethal junctional hemorrhage, 100% of animals treated with the propelled dressing survived to three hours, compared to 25% with a non-propelled version and about 38% with standard kaolin gauze.10PubMed Central. Self-propelled dressings containing thrombin and tranexamic acid improve short-term survival in a swine model of lethal junctional hemorrhage These are still largely experimental, but they illustrate how much design innovation is happening in this space.
Moving Into Civilian Medicine
For years, hemostatic dressings were almost exclusively a military product. That has changed substantially, though adoption is uneven. A survey of emergency medical services agencies in Pennsylvania found that fewer than half stocked hemostatic products. Among those that did, about 56% carried QuikClot Combat Gauze specifically. Half of the agencies carrying hemostatic products had used them at least once in the preceding six months.11PubMed Central. Availability and use of hemostatic agents in prehospital trauma patients in Pennsylvania translation from the military to the civilian setting Providers generally rated themselves as fairly comfortable using the products, even though actual deployments were infrequent.
A Dutch study of 66 civilian patients treated with chitosan gauze (ChitoGauze) in the field offers a clearer picture of real-world performance. Bleeding stopped completely in 46 of the 66 patients and was reduced in another 13. In seven patients the dressing failed to control hemorrhage, and user error contributed to three of those failures. Wounds were split fairly evenly between extremity injuries and head and face injuries. No side effects were observed during treatment, transport, or follow-up.12PubMed. Prehospital use of hemostatic dressings in emergency medical services in the Netherlands: A prospective study of 66 cases That failure rate of about 10% is a useful reality check: hemostatic dressings are very good, but they are not infallible, and proper technique is a recurring factor in the cases where they fall short.
The “Stop the Bleed” campaign in the United States has pushed hemostatic dressings into public awareness, encouraging workplaces, schools, and public buildings to stock bleeding-control kits alongside automated external defibrillators. The idea is that a bystander who can pack a wound and hold pressure with a hemostatic dressing might keep someone alive until paramedics arrive. The evidence on layperson use suggests that most people can do it, but training makes a significant difference in how well they maintain pressure long enough for the dressing to work.
Patients on Blood Thinners
One of the most practical questions about hemostatic dressings is whether they work in people taking anticoagulant medications like warfarin, heparin, or newer drugs like rivaroxaban and apixaban. These drugs impair the body’s clotting cascade, which is exactly the pathway that kaolin-based dressings rely on. The concern is that hemostatic dressings might not overcome the anticoagulant effect.
The evidence here is reassuring. An in vitro study tested kaolin-coated hemostatic material against blood from patients on multiple types of anticoagulants and found that the kaolin significantly improved the time to initial clot formation in all cases.13PubMed. In vitro effects of a kaolin-coated hemostatic dressing on anticoagulated blood The dressing did not completely normalize clotting, but it meaningfully accelerated it. For chitosan-based dressings, the picture is even clearer, since their mechanism does not depend on clotting factors at all.
A clinical trial in dental surgery patients on oral anticoagulant therapy compared a chitosan dressing (HemCon Dental Dressing) to standard care after tooth extractions and minor oral procedures. The chitosan-treated sites achieved hemostasis in about 1.5 minutes versus 4 minutes for control sites.14PubMed Central. Hemostasis and Post-operative Care of Oral Surgical Wounds by Hemcon Dental Dressing in Patients on Oral Anticoagulant Therapy That is a meaningful gap when you are managing a bleeding patient whose blood is pharmacologically less able to clot. In the Dutch prehospital study, 21 of the 66 patients treated with chitosan gauze were taking anticoagulants or had a clotting disorder, and the dressing still performed well across the group.12PubMed. Prehospital use of hemostatic dressings in emergency medical services in the Netherlands: A prospective study of 66 cases
Safety Considerations
Modern hemostatic dressings have a good safety record, but the field learned some hard lessons along the way. Early-generation products included loose granular agents (like the original QuikClot powder) that generated heat through an exothermic reaction when they contacted blood. Burns to wound tissue were a real concern. Newer gauze-impregnated products eliminated this problem by binding the active agent to the fabric, preventing loose particles from migrating into the wound and eliminating the heat issue.
An ideal hemostatic material should be biocompatible, biodegradable, and non-toxic to cells, while also adhering firmly in a wet environment.15PubMed Central. Hemostatic materials in wound care Some materials fall short on specific measures. Gelatin-based hemostats, for example, can swell significantly after application, which has occasionally caused foreign body reactions. In laboratory testing, even plain cotton gauze provoked high levels of inflammatory markers and complement system activation, which suggests that the baseline comparison is not entirely benign either.16PubMed. Hemostatic wound dressings: Predicting their effects by in vitro tests
One advantage of chitosan-based products on the safety front is the absence of particle release. A comparative study of chitosan gauze versus kaolin gauze noted that the chitosan product showed no particle shedding, which contributed to a superior safety profile.17The International Journal of Health Technology and Innovation. Evaluation of Hemostatic Effectiveness in a Standard Swine Hemorrhage Model of Severe Bleeding: A Comparative Study of Chitosan Gauze and Kaolin Gauze Particle migration into tissue or the bloodstream is a theoretical risk with any mineral-based dressing, though clinical complications from current-generation kaolin gauze have not been widely reported.
People with shellfish allergies sometimes ask whether chitosan dressings are safe for them. Shellfish allergy is triggered by proteins in the flesh of the shellfish, not by chitin (the carbohydrate in the shell from which chitosan is derived). Most manufacturers and allergy experts consider the risk negligible, though individual product labeling varies and the question has not been settled by a large clinical trial.
Use in Children
Hemostatic dressings were developed and tested primarily in adults, and the pediatric evidence base is genuinely thin. A recent review noted that while safety and efficacy are supported by robust preclinical and clinical data in adults, evidence for use in children remains limited.18PubMed. Quick clots for tiny spots: Hemostatic agents in action
What does exist is encouraging but small-scale. A case series of five children with severe bleeding disorders (median age two years) used a chitosan-based dressing for a total of six bleeding episodes. In four of those episodes, bleeding stopped immediately, eliminating the need for systemic clotting-factor therapy. There was no rebleeding after dressing removal and no adverse reactions or skin irritation.19Journal of Pediatric Hematology/Oncology. Chitosan-based Dressing for the Treatment of External/Accessible Bleedings in Children With Bleeding Tendency Five children is far too few to draw broad conclusions, but the finding that a topical dressing could substitute for intravenous clotting-factor replacement in some episodes is noteworthy, especially for families managing bleeding disorders at home.
Comparing Chitosan and Kaolin Head to Head
Because chitosan and kaolin dressings are the two dominant options in field trauma care, the question of which one is “better” comes up frequently. The honest answer is that they are closely matched in overall effectiveness, with each having advantages in specific situations.
In animal studies, both types achieve hemostasis reliably in straightforward hemorrhage models. One swine study comparing several hemostatic agents to standard gauze found no overall difference in initial hemostasis, rebleeding, or survival among the agents tested.20PubMed Central. Comparison of Celox-A, ChitoFlex, WoundStat, and combat gauze hemostatic agents versus standard gauze dressing in control of hemorrhage in a swine model of penetrating trauma Where the differences emerge is in edge cases. Chitosan’s independence from the coagulation cascade gives it an advantage in coagulopathic patients. Newer chitosan-kaolin composite dressings, which combine both agents, have shown improved hemostasis and survival compared to kaolin gauze alone in both rat and rabbit models.21PubMed Central. Design and Preclinical Evaluation of Chitosan/Kaolin Nanocomposites with Enhanced Hemostatic Efficiency
Chitosan gauze also tends to achieve hemostasis slightly faster and absorb more fluid, while kaolin gauze has a longer track record in military use and a more established supply chain. In practice, the choice between them often comes down to what an agency stocks and what providers have trained with, rather than a clear superiority of one over the other.
Smart Hemostatic Materials on the Horizon
Researchers are working on hemostatic materials that respond dynamically to conditions at the wound site. These “intelligent responsive” systems are designed to activate or change behavior in reaction to specific triggers: temperature, light, moisture, or even electrical signals.22Burns & Trauma. Advances in hemostatic biomaterials: biomimetic strategies, nanotechnology, and smart therapeutics The idea is that a dressing could sense whether bleeding has stopped and adjust its behavior accordingly, releasing additional clotting agents only when needed or dissolving itself once the wound has stabilized.
Some experimental dressings incorporate nanoparticles that concentrate clotting factors at the wound surface far more efficiently than current materials. Others borrow designs from nature, mimicking the adhesive proteins that mussels use to stick to wet rocks or the microstructures on gecko feet that create grip without glue. These biomimetic approaches aim to solve one of the persistent challenges with existing dressings: maintaining adhesion in a blood-soaked, slippery wound environment. None of these technologies are in widespread clinical use yet, but the pace of development has accelerated considerably in the past decade, driven partly by military funding and partly by growing civilian demand for bleeding-control products.
Dry fibrin sealant dressings represent a nearer-term advance. Unlike earlier fibrin patches that required refrigeration or complex preparation, newer formulations are shelf-stable and ready to apply. In a swine model of severe coagulopathic liver injury, a dry fibrin sealant dressing reduced posttreatment blood loss to about 670 mL, compared to roughly 3,300 mL with standard wound packing, and one-hour survival was 83% versus 0%.23Journal of Trauma and Acute Care Surgery. Dry Fibrin Sealant Dressings Reduce Blood Loss, Resuscitation Volume, and Improve Survival in Hypothermic Coagulopathic Swine with Grade V Liver Injuries Turning those results into a product that a combat medic or paramedic can carry in a pocket and apply under stress remains the engineering challenge, but the biological proof of concept is strong.